Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 7;144(19):2063-2066.
doi: 10.1182/blood.2024025681.

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Brooj Abro  1 , Matthew J Maurer  2 , Thomas M Habermann  3 , W Richard Burack  4 , Jennifer R Chapman  5 , Jonathon B Cohen  6 , Jonathan W Friedberg  7 , Giorgio Inghirami  8 , Brad S Kahl  9 , Melissa C Larson  2 , Brian K Link  10 , Izidore S Lossos  11 , Peter Martin  12 , Timothy J McDonnell  13 , Loretta J Nastoupil  14 , Shaun M Riska  2 , Sergei Syrbu  15 , Francisco Vega  13 , Kiran R Vij  16 , Christopher R Flowers  14 , James R Cerhan  2 , David L Jaye  1 , Andrew L Feldman  17
Affiliations

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Brooj Abro et al. Blood. .

Abstract

Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will affect <1% of non-Hodgkin lymphomas.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: F.V. has received research funding from Allogene, Caribou, and Geron Corporation. The remaining authors declare no competing financial interests.

References

    1. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. - PMC - PubMed
    1. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720–1748. - PMC - PubMed
    1. Campo E, Jaffe ES, Cook JR, et al. The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140(11):1229–1253. - PMC - PubMed
    1. Cerhan JR, Maurer MJ, Link BK, et al. The lymphoma epidemiology of outcomes cohort study: design, baseline characteristics, and early outcomes. Am J Hematol. 2024;99(3):408–421. - PMC - PubMed
    1. Matutes E. Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021? Expert Rev Hematol. 2021;14(4):355–363. - PubMed

LinkOut - more resources